To explore the role of p38MAPK/STAT1 in the progression of STMN1 promoting NSCLC metastasis, SB203580 and fludarabine were used to inhibit the activation of p38MAPK/STAT1. Here, STAT1 is linked to non-small cell lung carcinoma.